Can ritexitinib capsules treat seborrheic alopecia?

Ritlecitinib capsule (Ritlecitinib) is a selective Janus kinase (JAK) inhibitor, mainly used to treat severe alopecia areata in adolescents and adults aged 12 years and above. It modulates immune responses by inhibiting JAK1 and JAK3, thereby potentially promoting hair regeneration. However, its indications do not include seborrheic alopecia.

Seborrheic alopecia, also known as androgenic alopecia, is a type of hair loss related to abnormal androgen metabolism. It usually presents with symptoms such as an oily scalp, greasy hair, and thinning hair. This type of hair loss has a different pathogenesis than alopecia areata, so the treatments are also different.

Although ritexitinib has shown significant efficacy in the treatment of alopecia areata, there is currently no evidence that it can be used to treat seborrheic alopecia. Treatment of seborrheic alopecia usually requires other methods, such as changing dietary habits, paying attention to scalp cleaning, using specific medications, or undergoing surgery.

For seborrheic alopecia, patients can undergo systemic treatment under the guidance of a doctor. Commonly used medications include finasteride (primarily for male patients) and spironolactone or ethinyl estradiol cyproterone (for female patients), which can improve symptoms of hair loss. Additionally, topical medications such as minoxidil tincture can also be used to stimulate hair growth. In some severe or stubborn cases, hair transplant surgery may be an effective option.

In summary, ritexitinib capsules are not used to treat seborrheic alopecia. For patients with seborrheic alopecia, it is crucial to seek professional diagnosis and treatment advice. Doctors will develop an appropriate treatment plan based on the patient's specific situation to help control and improve hair loss symptoms.